T.Man Pharmaceutical Public Company Limited (SET: TMAN)
Health Care · Pharmaceuticals · TH
฿10.60
-1.85% today · -9.4% 1Y
T.Man Pharmaceutical Public Company Limited (SET: TMAN) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $128.00M.
Over the last twelve months the share price has lost 9.4%, trading between 9.95 and 13.60.
Tweenvest scores T.Man Pharmaceutical Public Company Limited across four factors: quality 68/100, value 83/100, growth 64/100, dividend 64/100. Its strongest factor is value.
TMAN price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $128.00M
- Revenue (TTM)
- $78.76M
- P/E
- 8.36
- EPS
- 1.30
- Dividend yield
- 6.04%
- Beta (5Y)
- —
- 52-week high
- ฿13.60
- 52-week low
- ฿9.95
- Avg volume (3M)
- —
- Shares outstanding
- 400.00M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,255.40 | +0.88% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.24 | +1.07% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF375.60 | +1.02% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £122.40 | +1.26% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.07 | +1.01% |
Figures last refreshed Aug 18, 2026.